Inter-platform reproducibility of ultrasound-based fat fraction for evaluating hepatic steatosis in nonalcoholic fatty liver disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Inter-platform reproducibility of ultrasound-based fat fraction for evaluating hepatic steatosis in nonalcoholic fatty liver disease ; volume:15 ; number:1 ; day:14 ; month:2 ; year:2024 ; pages:1-8 ; date:12.2024
Insights into imaging ; 15, Heft 1 (14.2.2024), 1-8, 12.2024

Creator: Jeon, Sun Kyung
Lee, Jeong Min

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13244-024-01611-0

URN: urn:nbn:de:101:1-2404221209179.355380896002

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:44 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Jeon, Sun Kyung
Lee, Jeong Min
SpringerLink (Online service)

Other Objects (12)

$Reproducibility of ultrasound-derived fat fraction in measuring hepatic steatosis$

Reproducibility of ultrasound-derived fat fraction in measuring hepatic steatosis

Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model

$Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content$

Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content

Association of chronic hepatitis B infection with hepatic steatosis and injury in nonalcoholic fatty liver disease children

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

MiR-103-3p promotes hepatic steatosis to aggravate nonalcoholic fatty liver disease by targeting of ACOX1

Melatonin: a potential intervention for hepatic steatosis

Role of SCAP/SREBP in Hepatic Steatosis

Betaine in ameliorating alcohol-induced hepatic steatosis

$Quantitative US fat fraction for noninvasive assessment of hepatic steatosis in suspected metabolic-associated fatty liver disease$

Quantitative US fat fraction for noninvasive assessment of hepatic steatosis in suspected metabolic-associated fatty liver disease

Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease

IκBζ regulates the development of nonalcoholic fatty liver disease through the attenuation of hepatic steatosis in mice

$Reproducibility of ultrasound-derived fat fraction in measuring hepatic steatosis$

Reproducibility of ultrasound-derived fat fraction in measuring hepatic steatosis

Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model

$Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content$

Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content

Association of chronic hepatitis B infection with hepatic steatosis and injury in nonalcoholic fatty liver disease children

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

MiR-103-3p promotes hepatic steatosis to aggravate nonalcoholic fatty liver disease by targeting of ACOX1

Melatonin: a potential intervention for hepatic steatosis

Role of SCAP/SREBP in Hepatic Steatosis

Betaine in ameliorating alcohol-induced hepatic steatosis

$Quantitative US fat fraction for noninvasive assessment of hepatic steatosis in suspected metabolic-associated fatty liver disease$

Quantitative US fat fraction for noninvasive assessment of hepatic steatosis in suspected metabolic-associated fatty liver disease

Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease

IκBζ regulates the development of nonalcoholic fatty liver disease through the attenuation of hepatic steatosis in mice

$Reproducibility of ultrasound-derived fat fraction in measuring hepatic steatosis$

Reproducibility of ultrasound-derived fat fraction in measuring hepatic steatosis

Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model

$Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content$

Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content

Association of chronic hepatitis B infection with hepatic steatosis and injury in nonalcoholic fatty liver disease children

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

MiR-103-3p promotes hepatic steatosis to aggravate nonalcoholic fatty liver disease by targeting of ACOX1

Melatonin: a potential intervention for hepatic steatosis

Role of SCAP/SREBP in Hepatic Steatosis

Betaine in ameliorating alcohol-induced hepatic steatosis

$Quantitative US fat fraction for noninvasive assessment of hepatic steatosis in suspected metabolic-associated fatty liver disease$

Quantitative US fat fraction for noninvasive assessment of hepatic steatosis in suspected metabolic-associated fatty liver disease

Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease

IκBζ regulates the development of nonalcoholic fatty liver disease through the attenuation of hepatic steatosis in mice

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Inter-platform reproducibility of ultrasound-based fat fraction for evaluating hepatic steatosis in nonalcoholic fatty liver disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Reproducibility of ultrasound-derived fat fraction in measuring hepatic steatosis

Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model

Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content

Association of chronic hepatitis B infection with hepatic steatosis and injury in nonalcoholic fatty liver disease children

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

MiR-103-3p promotes hepatic steatosis to aggravate nonalcoholic fatty liver disease by targeting of ACOX1

Melatonin: a potential intervention for hepatic steatosis

Role of SCAP/SREBP in Hepatic Steatosis

Betaine in ameliorating alcohol-induced hepatic steatosis

Quantitative US fat fraction for noninvasive assessment of hepatic steatosis in suspected metabolic-associated fatty liver disease

Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease

IκBζ regulates the development of nonalcoholic fatty liver disease through the attenuation of hepatic steatosis in mice

Reproducibility of ultrasound-derived fat fraction in measuring hepatic steatosis

Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model

Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content

Association of chronic hepatitis B infection with hepatic steatosis and injury in nonalcoholic fatty liver disease children

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

MiR-103-3p promotes hepatic steatosis to aggravate nonalcoholic fatty liver disease by targeting of ACOX1

Melatonin: a potential intervention for hepatic steatosis

Role of SCAP/SREBP in Hepatic Steatosis

Betaine in ameliorating alcohol-induced hepatic steatosis

Quantitative US fat fraction for noninvasive assessment of hepatic steatosis in suspected metabolic-associated fatty liver disease

Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease

IκBζ regulates the development of nonalcoholic fatty liver disease through the attenuation of hepatic steatosis in mice

Reproducibility of ultrasound-derived fat fraction in measuring hepatic steatosis

Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model

Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content

Association of chronic hepatitis B infection with hepatic steatosis and injury in nonalcoholic fatty liver disease children

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

MiR-103-3p promotes hepatic steatosis to aggravate nonalcoholic fatty liver disease by targeting of ACOX1

Melatonin: a potential intervention for hepatic steatosis

Role of SCAP/SREBP in Hepatic Steatosis

Betaine in ameliorating alcohol-induced hepatic steatosis

Quantitative US fat fraction for noninvasive assessment of hepatic steatosis in suspected metabolic-associated fatty liver disease

Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease

IκBζ regulates the development of nonalcoholic fatty liver disease through the attenuation of hepatic steatosis in mice

Related objects

Reset password